Prostate cancer advances help extend a patient's life

September 11, 2018 | Dory Benford

Johnny Lopez's research into the latest prostate cancer treatments, clinical trials, experimental therapies — anything to avoid chemotherapy, and a recommendation from a friend also battling prostate cancer, led him to Tanya Dorff, M.D., and City of Hope.

Continue Reading

New Genome-editing Platform Poised to Fuel the Next Generation of Genetic Medicines

July 16, 2018 | Zen Vuong

A novel gene-editing tool discovered at City of Hope has the potential to treat a variety of genetic diseases.

Researcher's Ovarian Cancer Discovery Takes on Special Meaning

June 27, 2018 | City of Hope

The results of a study published earlier this year by TGen researchers (City of Hope affiliate) in the journal Clinical Cancer Research suggest an existing leukemia drug, ponatinib, shows promise against SCCOHT.

Cancer Urban Legend: Cancer Runs in My Family, I Can’t Reduce My Risk

February 13, 2018 | Abe Rosenberg

As knowledge of cancer's genetic nature expands, so do the treatment options. Learn more from Thomas Slavin, M.D., clinical geneticist at City of Hope.

City of Hope's CAR T Work Gets a Boost from TGen

January 30, 2018 | City of Hope

As an affiliate of City of Hope, TGen will use its genomics expertise to chart a path to greater precision in CAR T therapies for cancer patients.

Really Big Data: How Genomics Is Poised to Reshape Cancer Care

November 9, 2017 | Abe Rosenberg

The exploding field of cancer genomics is enabling that kind of prediction for a growing number of inherited cancers, like identifying one of the many genes beyond BRCA1 and BRCA2 gene mutations linked to breast cancer.

TGen Spotlight: New Study Tackles Sports-Related Concussions

October 16, 2017 | City of Hope

TGen-Riddell partnership results could help future studies lead to advanced methods of injury and disease detection

City of Hope collaborates with The Jackson Laboratory to help speed research discoveries into cures

July 11, 2017 | Denise Heady

A collaboration with The Jackson Laboratory expands access to leading-edge research capabilities to find new treatments for life-threatening diseases.

City of Hope's Steven T. Rosen, M.D., on the Impact of the TGen Alliance

December 1, 2016 | City of Hope

In this Q and A, Steven T. Rosen, M.D., provost and chief scientific officer for City of Hope, answers questions about the importance of precision of medicine in the fight against cancer and how the City of Hope and TGen alliance will advance research and treatment using this approach.